Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aurinia Pharm Ord
(NQ:
AUPH
)
4.910
+0.040 (+0.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharm Ord
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
Unusual Options Activity Insight: Aurinia Pharmaceuticals
June 03, 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Thursday. The stock price moved down to $13.6 following the option alert. Sentiment: BEARISH...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
June 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients
May 21, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced a supportive interim analysis of its AURORA 2 continuation study evaluating Lupkynis (voclosporin) in...
Via
Benzinga
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis
May 20, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
May 19, 2021
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.
Via
The Motley Fool
Exposures
COVID-19
Another Tough Day For Markets
May 17, 2021
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”
Via
Talk Markets
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
May 14, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Heavy Global Erosion
May 11, 2021
It is an everything-down day. Even the news is down because commenters are being careful.
Via
Talk Markets
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis
May 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Exposures
COVID-19
Product Safety
Stocks That Hit 52-Week Lows On Monday
May 10, 2021
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....
Via
Benzinga
Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet
May 10, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced that The Lancet published its Phase 3 AURORA 1 study evaluating Lupkynis (voclosporin) in adults with...
Via
Benzinga
Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS™ (voclosporin) in The Lancet
May 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Calm Markets Day
May 07, 2021
Despite seriously disappointing April jobless numbers, markets are gaining all the same.
Via
Talk Markets
70 Biggest Movers From Friday
May 10, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...
Via
Benzinga
Cramer Shares His Thoughts On Atkore, Petco And More
May 07, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers American Electric Power Company Inc (NASDAQ: AEP) over Consolidated Edison, Inc. (NYSE: ED). If...
Via
Benzinga
56 Stocks Moving In Friday's Mid-Day Session
May 07, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 07, 2021
Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
32 Stocks Moving in Friday's Pre-Market Session
May 07, 2021
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:...
Via
Benzinga
Why Aurinia Pharmaceuticals Stock Is Crashing Today
May 06, 2021
Expectations for the biotech's first-quarter sales may have been too high.
Via
The Motley Fool
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
May 06, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021
April 28, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.